Skip to main content
. 2016 Oct 15;7(48):79292–79304. doi: 10.18632/oncotarget.12685

Figure 1. Pictures of athymic nude mice bearing NCI-H295R xenografts and H&E sections of clones 1.

Figure 1

A, B. and 2 C, D. Representative CD31 E, F. and Ki67 H, I. stainings as well as the quantification of blood vessels cross sections G. and proliferation index J. of clone 1 and 2 tumors. Effects on tumor size of NCI-H295R xenografts of clone 1 K. and clone 2 L. after two therapeutic cycles with EDP-M (etoposide, doxorubicin, cisplatin and mitotane) and LEDP-M (etoposide, liposomal doxorubicin, liposomal cisplatin and mitotane). Stars denote significant differences compared with EDP-M.